Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr;66(4):429-32.
doi: 10.1136/ard.2006.067033.

Is there a microangiopathic antiphospholipid syndrome?

Review

Is there a microangiopathic antiphospholipid syndrome?

Ronald A Asherson et al. Ann Rheum Dis. 2007 Apr.

Abstract

Revealing the evolution of the term APS and its commonalities with other microangiopathic disorders

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Asherson R A, Merry P, Acheson J F, Harris E N, Hughes G R V. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the “primary” antiphospholipid syndrome. Ann Rheum Dis 198948358–361. - PMC - PubMed
    1. Asherson R A. Subungual splinter hemorrhages: a new sign of antiphospholipid coagulopathy? Ann Rheum Dis 199049268 - PMC - PubMed
    1. Francès C, Piette J C, Saada V, Papo T, Wechsler B, Chosidow O.et al Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature. Lupus 19943123–128. - PubMed
    1. Francès C, Piette J C, Asherson R A. Dermatological aspects of antiphospholipid antibody syndrome. In: Sarzi Puttini P, Doria A, Girolomoni G, Kuhn A, eds. Handbook of systemic autoimmune diseases. Vol 5. Amsterdam,Elsevier 2006103–118.
    1. Von Landenberg P, Asherson R A, Piette J C. Renal, hepatic and other intraabdominal manifestations in the antiphospholipid syndrome. In: Asherson RA, Cervera R, Piette JC, Shoenfeld J, eds. The antiphospholipid syndrome 11. Amsterdam: Elsevier Science, 2002189–204.

MeSH terms

Substances